[Asia Economy Reporter Minji Lee] Hugel announced on the 23rd that it has obtained sales approval for Botulinum Toxin Type A for Injection in China.
The company stated, "Entering the major market of China will contribute to the expansion of overseas sales," and added, "We plan to launch the product locally within this year."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
